The New York and Presbyterian Hospital — New York, New York

The New York and Presbyterian Hospital is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

The New York and Presbyterian Hospital has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Myelodysplastic Syndrome, Acute Myeloid Leukemia, Sedation.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Sedana Medical.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The New York and Presbyterian Hospital?

The New York and Presbyterian Hospital has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The New York and Presbyterian Hospital conducted?

The New York and Presbyterian Hospital has 2 clinical trials on record, with 1 currently active. Their work covers Myelodysplastic Syndrome, Acute Myeloid Leukemia, Sedation.

Is The New York and Presbyterian Hospital accredited by Crixeo Health?

The New York and Presbyterian Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The New York and Presbyterian Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.